Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

Validating bioluminescence imaging as a high-throughput, quantitative modality for assessing tumor burden.

Paroo Z, Bollinger RA, Braasch DA, Richer E, Corey DR, Antich PP, Mason RP.

Mol Imaging. 2004 Apr;3(2):117-24.

PMID:
15296676
2.

Quantitative bioluminescence imaging of mouse tumor models.

Tseng JC, Kung AL.

Cold Spring Harb Protoc. 2015 Jan 5;2015(1):pdb.prot078261. doi: 10.1101/pdb.prot078261.

PMID:
25561617
3.

Use of in vivo bioluminescence imaging to predict hepatic tumor burden in mice.

Sarraf-Yazdi S, Mi J, Dewhirst MW, Clary BM.

J Surg Res. 2004 Aug;120(2):249-55.

PMID:
15234220
4.

Noninvasive visualization of tumor growth in a human colorectal liver metastases xenograft model using bioluminescence in vivo imaging.

Thalheimer A, Korb D, Bönicke L, Wiegering A, Mühling B, Schneider M, Koch S, Riedel SS, Germer CT, Beilhack A, Brändlein S, Otto C.

J Surg Res. 2013 Nov;185(1):143-51. doi: 10.1016/j.jss.2013.03.024.

PMID:
23998649
5.

Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis.

Jenkins DE, Oei Y, Hornig YS, Yu SF, Dusich J, Purchio T, Contag PR.

Clin Exp Metastasis. 2003;20(8):733-44.

PMID:
14713107
6.
7.

In vivo bioluminescence imaging of tumor hypoxia dynamics of breast cancer brain metastasis in a mouse model.

Saha D, Dunn H, Zhou H, Harada H, Hiraoka M, Mason RP, Zhao D.

J Vis Exp. 2011 Oct 3;(56). pii: 3175. doi: 10.3791/3175.

8.

Continuous delivery of D-luciferin by implanted micro-osmotic pumps enables true real-time bioluminescence imaging of luciferase activity in vivo.

Gross S, Abraham U, Prior JL, Herzog ED, Piwnica-Worms D.

Mol Imaging. 2007 Mar-Apr;6(2):121-30.

PMID:
17445506
9.

Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice.

Burgos JS, Rosol M, Moats RA, Khankaldyyan V, Kohn DB, Nelson MD Jr, Laug WE.

Biotechniques. 2003 Jun;34(6):1184-8.

PMID:
12813886
10.

Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging.

Inoue Y, Kiryu S, Izawa K, Watanabe M, Tojo A, Ohtomo K.

Eur J Nucl Med Mol Imaging. 2009 May;36(5):771-9. doi: 10.1007/s00259-008-1022-8.

PMID:
19096841
11.

The expression level of luciferase within tumour cells can alter tumour growth upon in vivo bioluminescence imaging.

Brutkiewicz S, Mendonca M, Stantz K, Comerford K, Bigsby R, Hutchins G, Goebl M, Harrington M.

Luminescence. 2007 May-Jun;22(3):221-8.

PMID:
17286245
12.

Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals.

Klerk CP, Overmeer RM, Niers TM, Versteeg HH, Richel DJ, Buckle T, Van Noorden CJ, van Tellingen O.

Biotechniques. 2007 Jul;43(1 Suppl):7-13, 30. Review.

13.

Complementary use of bioluminescence imaging and contrast-enhanced micro-computed tomography in an orthotopic brain tumor model.

Yahyanejad S, Granton PV, Lieuwes NG, Gilmour L, Dubois L, Theys J, Chalmers AJ, Verhaegen F, Vooijs M.

Mol Imaging. 2014;13. doi: 10.2310/7290.2014.00038.

PMID:
25743108
14.

High-throughput quantitative bioluminescence imaging for assessing tumor burden.

Contero A, Richer E, Gondim A, Mason RP.

Methods Mol Biol. 2009;574:37-45. doi: 10.1007/978-1-60327-321-3_4.

15.

In vivo bioluminescence imaging.

Sato A, Klaunberg B, Tolwani R.

Comp Med. 2004 Dec;54(6):631-4. Review.

PMID:
15679260
16.

Rapid and quantitative assessment of cancer treatment response using in vivo bioluminescence imaging.

Rehemtulla A, Stegman LD, Cardozo SJ, Gupta S, Hall DE, Contag CH, Ross BD.

Neoplasia. 2000 Nov-Dec;2(6):491-5.

17.

Dynamic bioluminescence imaging for quantitative tumour burden assessment using IV or IP administration of D: -luciferin: effect on intensity, time kinetics and repeatability of photon emission.

Keyaerts M, Verschueren J, Bos TJ, Tchouate-Gainkam LO, Peleman C, Breckpot K, Vanhove C, Caveliers V, Bossuyt A, Lahoutte T.

Eur J Nucl Med Mol Imaging. 2008 May;35(5):999-1007. doi: 10.1007/s00259-007-0664-2.

PMID:
18180921
18.

In vivo bioluminescence imaging of murine xenograft cancer models with a red-shifted thermostable luciferase.

Mezzanotte L, Fazzina R, Michelini E, Tonelli R, Pession A, Branchini B, Roda A.

Mol Imaging Biol. 2010 Aug;12(4):406-14. doi: 10.1007/s11307-009-0291-3.

PMID:
19937390
19.

Bioluminescence imaging correlates with tumor progression in an orthotopic mouse model of lung cancer.

Madero-Visbal RA, Colon JF, Hernandez IC, Limaye A, Smith J, Lee CM, Arlen PA, Herrera L, Baker CH.

Surg Oncol. 2012 Mar;21(1):23-9. doi: 10.1016/j.suronc.2010.07.008.

PMID:
20801643
20.

A synthetic luciferin improves bioluminescence imaging in live mice.

Evans MS, Chaurette JP, Adams ST Jr, Reddy GR, Paley MA, Aronin N, Prescher JA, Miller SC.

Nat Methods. 2014 Apr;11(4):393-5. doi: 10.1038/nmeth.2839. Erratum in: Nat Methods. 2014 Apr;11(4):395.

Items per page

Supplemental Content

Support Center